Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.58 USD | +1.00% | -3.46% | -48.26% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 10M | Capitalization | 345M |
---|---|---|---|---|---|
Net income 2024 * | -71M | Net income 2025 * | -86M | EV / Sales 2024 * | - |
Net cash position 2024 * | 311M | Net cash position 2025 * | 430M | EV / Sales 2025 * | -8.48 x |
P/E ratio 2024 * |
-4.57
x | P/E ratio 2025 * |
-4.43
x | Employees | 44 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 77.39% |
Latest transcript on Tourmaline Bio, Inc.
1 day | -1.54% | ||
1 week | -7.62% | ||
Current month | -15.03% | ||
1 month | -14.22% | ||
3 months | -64.50% | ||
6 months | -29.73% | ||
Current year | -48.62% |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 17 M€ | +5.06% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 13.54 | +0.71% | 343 733 |
24-05-24 | 13.45 | -1.54% | 326,966 |
24-05-23 | 13.66 | +0.22% | 340,914 |
24-05-22 | 13.63 | -2.85% | 186,986 |
24-05-21 | 14.03 | -3.64% | 247,444 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.62% | 345M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.48% | 22.1B | |
-9.35% | 18.34B | |
-41.70% | 16.59B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- TRML Stock